Pineapple Energy Announces Appointment of Chief Operating Officer
MINNETONKA, Minn., May 30, 2024 (GLOBE NEWSWIRE) — Scott Maskin, Interim CEO of Pineapple Energy Inc. (“Pineapple” or the “Company”), […]
ADC Therapeutics nimmt an der Jefferies Global Healthcare Conference teil
LAUSANNE, Schweiz, May 31, 2024 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) gab heute bekannt, dass Ameet Mallik, Chief […]
San Diego County Regional Public Safety Agencies Launch Genasys EVAC for Enhanced Emergency Communication
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications, is pleased […]
NowVertical Group Reports First Quarter 2024 Financial Results
Q1 2024 Revenue was $12.9 million, an increase of 3% over Q1 2023 Q1 2024 Income from Operations was $0.2 […]
Patagonia Gold Quarter 1 2024 Financial Results
VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) — Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSXV: PGDC) announces its […]
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company […]
O2Gold Closes First Tranche of Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, May 30, 2024 (GLOBE […]
Goodness Growth Holdings to Complete Non-Brokered Private Placement to Support the Relocation of a Minnesota Dispensary
MINNEAPOLIS, May 30, 2024 (GLOBE NEWSWIRE) — Goodness Growth Holdings, Inc. (“Goodness Growth” or the “Company”) (CSE: GDNS; OTCQX: GDNSF), […]
Plug to Webcast Annual Shareholder Meeting on June 5, 2024
LATHAM, N.Y., May 30, 2024 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions […]
Rakovina Therapeutics Announces 2024 Q1 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX.V: RKV), (the “Company”) a biopharmaceutical company committed […]
